We are a clinical genomics service provider with comprehensive genomic services to support drug discovery, translational medicine, clinical development, and precision medicine including CDx.
From high-throughput ADME screening services and human clearance predictions to support drug metabolism and pharmacokinetics studies to drug-drug interaction testing and metabolite profiling to support clinical safety, the Q2 Solutions global network offers solutions to support every phase of drug discovery and development.
As an industry leader clinical trial laboratory services, Q2 Solutions can help you make informed development decisions about your drug candidates by offering an array of high-throughput ADME screening and DMPK services that use validated bioanalytical methods to support candidate identification and characterization.
Rules-Based Medicine is the world’s leading multiplexed immunoassay testing laboratory that solves complex drug development challenges with innovative biomarker services and a novel whole blood immunophenotyping device.
Translational biomarker solutions to accelerate the adoption of assays into clinical trials though new technology evaluation and early biomarker discovery.
Our vaccine laboratory services are supported by global, comprehensive central laboratory services to meet your development needs across the entire vaccine development life cycle.